Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Heart Test Laboratories, Inc. ( (HSCS) ) just unveiled an update.
HeartSciences Inc. announced a securities offering with the SEC for up to 4,285,714 units at $3.50 per unit, totaling a maximum of $15 million. Each unit includes one share of Series D Convertible Preferred Stock and a warrant to purchase common stock. The preferred stock, which ranks senior to common stock, is convertible into common stock and has no voting rights. The company may require conversion under certain conditions, and the stock is non-redeemable and perpetual.
The most recent analyst rating on (HSCS) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Heart Test Laboratories, Inc. stock, see the HSCS Stock Forecast page.
Spark’s Take on HSCS Stock
According to Spark, TipRanks’ AI Analyst, HSCS is a Neutral.
The overall stock score is significantly impacted by the company’s poor financial performance and negative valuation metrics. Despite some positive technical indicators, the financial instability poses substantial risks to long-term investment viability.
To see Spark’s full report on HSCS stock, click here.
More about Heart Test Laboratories, Inc.
Average Trading Volume: 15,104
Technical Sentiment Signal: Sell
Current Market Cap: $4.63M
For an in-depth examination of HSCS stock, go to TipRanks’ Stock Analysis page.